Column Group IV-A, LP insider trades: Eikon Therapeutics (EIKN) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Column Group IV-A, LP reports to the SEC
Open-market buys and sales
28 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | EIKN | ↑ Buy | 89,200 | $11.56 | $1.0M | Indirect | Sep 8, 2026 (5d) |
| Feb 6, 2026 | EIKN | ↑ Buy | 1,437,323 | $18.00 | $25.9M | By The Column Group IV, LP | Feb 9, 2026 (3d) |
| Feb 6, 2026 | EIKN | ↑ Buy | 630,881 | $18.00 | $11.4M | By The Column Group Opportunity III, LP | Feb 9, 2026 (3d) |
| Feb 6, 2026 | EIKN | ↑ Buy | 49,556 | $18.00 | $892K | By The Column Group IV-A, LP | Feb 9, 2026 (3d) |
| Nov 16, 2023 | NGM | ↑ Buy | 22,631 | $0.69 | $16K | Indirect | Nov 17, 2023 (1d) |
| Jan 31, 2023 | NGM | ↑ Buy | 184,272 | $5.00 | $921K | Indirect | Feb 1, 2023 (1d) |
| Jan 23, 2023 | NGM | ↑ Buy | 9,900 | $5.00 | $49K | Indirect | Jan 25, 2023 (2d) |
| Jan 20, 2023 | NGM | ↑ Buy | 38,139 | $5.00 | $191K | Indirect | Jan 23, 2023 (3d) |
| Jan 12, 2023 | NGM | ↑ Buy | 5,378 | $4.95 | $27K | Indirect | Jan 17, 2023 (5d) |
| Jan 11, 2023 | NGM | ↑ Buy | 309,070 | $4.79 | $1.5M | Indirect | Jan 12, 2023 (1d) |
| Dec 12, 2022 | NGM | ↑ Buy | 300 | $4.98 | $1K | Indirect | Dec 14, 2022 (2d) |
| Nov 22, 2022 | NGM | ↑ Buy | 40,327 | $5.00 | $202K | Indirect | Nov 23, 2022 (1d) |
| Nov 4, 2022 | NGM | ↑ Buy | 139,148 | $4.92 | $684K | Indirect | Nov 7, 2022 (3d) |
| Oct 27, 2022 | NGM | ↑ Buy | 76,877 | $4.86 | $374K | Indirect | Oct 31, 2022 (4d) |
| Oct 26, 2022 | NGM | ↑ Buy | 123,820 | $4.81 | $595K | Indirect | Oct 27, 2022 (1d) |
| Jun 9, 2022 | NGM | ↑ Buy | 984,161 | $13.50 | $13.3M | Indirect | Jun 13, 2022 (4d) |
| Jun 2, 2022 | NGM | ↑ Buy | 34,200 | $13.03 | $446K | Indirect | Jun 6, 2022 (4d) |
| Jun 1, 2022 | NGM | ↑ Buy | 153,806 | $13.46 | $2.1M | Indirect | Jun 2, 2022 (1d) |
| May 27, 2022 | NGM | ↑ Buy | 22,911 | $13.49 | $309K | Indirect | May 31, 2022 (4d) |
| May 25, 2022 | RAPT | ↑ Buy | 1,900 | $12.45 | $24K | Indirect | May 27, 2022 (2d) |
| May 25, 2022 | NGM | ↑ Buy | 61,120 | $13.42 | $820K | Indirect | May 26, 2022 (1d) |
| May 24, 2022 | RAPT | ↑ Buy | 26,550 | $12.19 | $324K | Indirect | May 25, 2022 (1d) |
| May 20, 2022 | NGM | ↑ Buy | 39,700 | $13.36 | $530K | Indirect | May 23, 2022 (3d) |
| May 18, 2022 | NGM | ↑ Buy | 151,699 | $13.33 | $2.0M | Indirect | May 19, 2022 (1d) |
| May 16, 2022 | NGM | ↑ Buy | 33,166 | $12.90 | $428K | Indirect | May 17, 2022 (1d) |
| May 12, 2022 | NGM | ↑ Buy | 166,350 | $11.43 | $1.9M | Indirect | May 13, 2022 (1d) |
| May 10, 2022 | RAPT | ↑ Buy | 1,250,000 | $10.67 | $13.3M | Indirect | May 12, 2022 (2d) |
| May 10, 2022 | NGM | ↑ Buy | 114,440 | $10.95 | $1.3M | Indirect | May 11, 2022 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other EIKN insiders
Open-market trades in the last 12 months
About Column Group IV-A, LP's insider trades
Column Group IV-A, LP is an insider at Eikon Therapeutics (EIKN). Since May 10, 2022, it has reported 28 open-market purchases worth $80.4M and no sales on SEC Form 4. In the last 12 months: 4 buys ($39.2M).
Its filings also include other transactions (2 filings), conversions (1 filing), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EIKN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.